deoxyribose has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allemann, O; Bissantz, C; Burgy, G; Diederich, F; Ehler, A; Ellermann, M; Grünstein, D; Jakob-Roetne, R; Lerner, C; Paulini, R; Rudolph, MG; Stihle, M; Tissot, H | 1 |
| Battisti, C; Federico, A; Formichi, P; Radi, E | 1 |
2 other study(ies) available for deoxyribose and Parkinson Disease
| Article | Year |
|---|---|
Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors.
Topics: Binding Sites; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Crystallography, X-Ray; Deoxyribose; Dopamine; Drug Design; Levodopa; Models, Molecular; Parkinson Disease; Ribose; S-Adenosylmethionine | 2012 |
Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.
Topics: Adult; alpha-Synuclein; Apoptosis; Deoxyribose; DNA Mutational Analysis; Environment; Flow Cytometry; Genetic Predisposition to Disease; Genotype; Humans; Immunity, Innate; Lymphocytes; Male; Mutation; Oxidative Stress; Parkinson Disease | 2008 |